0001415889-20-002946.txt : 20201216 0001415889-20-002946.hdr.sgml : 20201216 20201216191847 ACCESSION NUMBER: 0001415889-20-002946 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201214 FILED AS OF DATE: 20201216 DATE AS OF CHANGE: 20201216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Schueren Robert Alan CENTRAL INDEX KEY: 0001597341 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 201393797 MAIL ADDRESS: STREET 1: 7400 PASEO PADRE PARKWAY CITY: FREMONT STATE: CA ZIP: 94555 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 201 INDUSTRIAL ROAD STREET 2: SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 form4-12162020_041235.xml X0306 4 2020-12-14 0001604821 Natera, Inc. NTRA 0001597341 Schueren Robert Alan C/O NATERA, INC. 201 INDUSTRIAL ROAD SUITE 410 SAN CARLOS CA 94070 false true false false CHIEF OPERATING OFFICER Common Stock 2020-12-14 4 M 0 10000 13.01 A 62855 D Common Stock 2020-12-14 4 S 0 400 97.375 D 62455 D Common Stock 2020-12-14 4 S 0 440 99.2855 D 62015 D Common Stock 2020-12-14 4 S 0 11640 100.0132 D 50375 D Common Stock 2020-12-14 4 S 0 2605 101.4811 D 47770 D Common Stock 2020-12-14 4 S 0 4915 102.207 D 42855 D Stock Option (right to buy) 13.01 2020-12-14 4 M 0 10000 0 D 2029-01-10 Common Stock 10000 67500 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2020. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.00 to $97.78 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $98.67 to $99.54 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.84 to $100.72 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.915 to $101.90 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.94 to $102.49 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The option shares vest over four years. 25% of the option shares vested and became exercisable on January 7, 2020 and the remaining shares vest in 36 equal monthly installments thereafter. /s/ Tami Chen, Attorney-in-Fact 2020-12-16